IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

20/20 Biolabs Inc (AIDX)

CUSIP: 90138K101 | NYSE | Healthcare · Medical Devices | Micro Cap | 18 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13DJonathan M Cohen1,833,75016.8%New 5%+ stakeMar 3, 2026No 13F filer matched
13DJonathan M Cohen1,833,750
16.8% of class · Mar 3, 2026

Institutional Holders — Q3 2026

Geode Capital Management, LLC54,493
0.0% of portfolio›$23.8K
Mcdonald Partners LLC2,800
0.0% of portfolio›$1.2K
Signaturefd, LLC767
0.0% of portfolio›$335
UBS Group AG580
0.0% of portfolio›$252
Allworth Financial LP172
0.0% of portfolio›$95
Citigroup Inc1
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Geode Capital Management, LLC
54,493$23.8K0.0%IndexVery LowBoston, MA2026-11-06
Mcdonald Partners LLC
2,800$1.2K0.0%CoreLowCleveland, OH2026-11-03
Signaturefd, LLC
767$3350.0%IndexLowAtlanta, GA2026-10-23
UBS Group AG
580$2520.0%CoreMediumZurich, Switzerland2026-11-10
Allworth Financial LP
172$950.0%ETFLowFolsom, CA2026-11-06
Citigroup Inc
1$00.0%CoreMediumNew York, NY2026-11-04
New 5%+ stake
No 13F filer matched